bisantrene has been researched along with Kidney Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, G; Coltman, CA; Kuhn, J; Myers, JW; Pocelinko, R; Sandbach, JF; Von Hoff, DD | 1 |
| Faye, L; Scher, H; Schwartz, S; Watson, R; Yagoda, A | 1 |
| Davis, TE; Earhart, RH; Elson, PJ; Gumas, L; Keller, AM; Kies, MS; Kvols, LK; Spiegel, R; Stevens, C; Trump, DL | 1 |
| Blackstein, ME; Evans, WK; Osoba, D; Shepherd, FA; Taylor, D | 1 |
4 other study(ies) available for bisantrene and Kidney Neoplasms
| Article | Year |
|---|---|
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942).
Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Bone Marrow; Carcinoma, Hepatocellular; Drug Evaluation; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis | 1981 |
Phase II trial of bisantrene for advanced hypernephroma.
Topics: Adenocarcinoma; Anthracenes; Antineoplastic Agents; Drug Evaluation; Humans; Kidney Neoplasms | 1982 |
Phase II studies of PCNU and bisantrene in advanced renal cell carcinoma.
Topics: Adult; Aged; Anthracenes; Carcinoma, Renal Cell; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Nitrosourea Compounds | 1987 |
Phase II evaluation of bisantrene in patients with advanced renal cell carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Phlebitis | 1985 |